APO Research
Talk to an analyst

APO RESEARCH · REPORT

HMG-CoA Reductase Inhibitors

Compare research editions
View pricing & licenses

Selected research

Industry Research

HMG-CoA Reductase Inhibitors Industry Research Report 2026

27 December 2025139 pages

Choose your research edition.

Industry ResearchHMG-CoA Reductase Inhibitors Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal HMG-CoA Reductase Inhibitors Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal HMG-CoA Reductase Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal HMG-CoA Reductase Inhibitors Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal HMG-CoA Reductase Inhibitors Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global HMG-CoA Reductase Inhibitors market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for HMG-CoA Reductase Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for HMG-CoA Reductase Inhibitors is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for HMG-CoA Reductase Inhibitors is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of HMG-CoA Reductase Inhibitors include CTTQ, Simcere, Wanbang Biopharmaceuticals, Lek Pharmaceuticals, Qilu Pharmaceutical, Novartis, Merck Sharp & Dohme, Lepu Pharmaceuticals and Jiurui Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global HMG-CoA Reductase Inhibitors market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

HMG-CoA Reductase Inhibitors Market by Company

CTTQ

Simcere

Wanbang Biopharmaceuticals

Lek Pharmaceuticals

Qilu Pharmaceutical

Novartis

Merck Sharp & Dohme

Lepu Pharmaceuticals

Jiurui Health

Jialin Pharmaceutical

Dinuo Pharmaceutical

Hanhui Pharmaceuticals

Daiichi Sankyo

Sanofi-Aventis

Pfizer

AstraZeneca

HMG-CoA Reductase Inhibitors Segment by Type

Simvastatin

Rosuvastatin

Atorvastatin

Others

HMG-CoA Reductase Inhibitors Segment by Application

Hospital

Clinic

Others

HMG-CoA Reductase Inhibitors Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HMG-CoA Reductase Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of HMG-CoA Reductase Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HMG-CoA Reductase Inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of HMG-CoA Reductase Inhibitors manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of HMG-CoA Reductase Inhibitors by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of HMG-CoA Reductase Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global HMG-CoA Reductase Inhibitors Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global HMG-CoA Reductase Inhibitors Sales (Units) of Manufacturers (2021-2026) Table 7. Global HMG-CoA Reductase Inhibitors Sales Market Share by Manufacturers (2021-2026) Table 8. Global HMG-CoA Reductase Inhibitors Revenue of Manufacturers (2021-2026) Table 9. Global HMG-CoA Reductase Inhibitors Revenue Share by Manufacturers (2021-2026) Table 10. Global Market HMG-CoA Reductase Inhibitors Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global HMG-CoA Reductase Inhibitors Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of HMG-CoA Reductase Inhibitors, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of HMG-CoA Reductase Inhibitors, Product Type & Application Table 14. Global HMG-CoA Reductase Inhibitors Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global HMG-CoA Reductase Inhibitors by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. CTTQ Company Information Table 19. CTTQ Business Overview Table 20. CTTQ HMG-CoA Reductase Inhibitors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. CTTQ HMG-CoA Reductase Inhibitors Product Portfolio Table 22. CTTQ Recent Developments Table 23. Simcere Company Information Table 24. Simcere Business Overview Table 25. Simcere HMG-CoA Reductase Inhibitors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Simcere HMG-CoA Reductase Inhibitors Product Portfolio Table 27. Simcere Recent Developments Table 28. Wanbang Biopharmaceuticals Company Information Table 29. Wanbang Biopharmaceuticals Business Overview Table 30. Wanbang Biopharmaceuticals HMG-CoA Reductase Inhibitors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Wanbang Biopharmaceuticals HMG-CoA Reductase Inhibitors Product Portfolio Table 32. Wanbang Biopharmaceuticals Recent Developments Table 33. Lek Pharmaceuticals Company Information Table 34. Lek Pharmaceuticals Business Overview Table 35. Lek Pharmaceuticals HMG-CoA Reductase Inhibitors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Lek Pharmaceuticals HMG-CoA Reductase Inhibitors Product Portfolio Table 37. Lek Pharmaceuticals Recent Developments Table 38. Qilu Pharmaceutical Company Information Table 39. Qilu Pharmaceutical Business Overview Table 40. Qilu Pharmaceutical HMG-CoA Reductase Inhibitors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Qilu Pharmaceutical HMG-CoA Reductase Inhibitors Product Portfolio Table 42. Qilu Pharmaceutical Recent Developments Table 43. Novartis Company Information Table 44. Novartis Business Overview Table 45. Novartis HMG-CoA Reductase Inhibitors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Novartis HMG-CoA Reductase Inhibitors Product Portfolio Table 47. Novartis Recent Developments Table 48. Merck Sharp & Dohme Company Information Table 49. Merck Sharp & Dohme Business Overview Table 50. Merck Sharp & Dohme HMG-CoA Reductase Inhibitors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Merck Sharp & Dohme HMG-CoA Reductase Inhibitors Product Portfolio Table 52. Merck Sharp & Dohme Recent Developments Table 53. Lepu Pharmaceuticals Company Information Table 54. Lepu Pharmaceuticals Business Overview Table 55. Lepu Pharmaceuticals HMG-CoA Reductase Inhibitors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Lepu Pharmaceuticals HMG-CoA Reductase Inhibitors Product Portfolio Table 57. Lepu Pharmaceuticals Recent Developments Table 58. Jiurui Health Company Information Table 59. Jiurui Health Business Overview Table 60. Jiurui Health HMG-CoA Reductase Inhibitors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Jiurui Health HMG-CoA Reductase Inhibitors Product Portfolio Table 62. Jiurui Health Recent Developments Table 63. Jialin Pharmaceutical Company Information Table 64. Jialin Pharmaceutical Business Overview Table 65. Jialin Pharmaceutical HMG-CoA Reductase Inhibitors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Jialin Pharmaceutical HMG-CoA Reductase Inhibitors Product Portfolio Table 67. Jialin Pharmaceutical Recent Developments Table 68. Dinuo Pharmaceutical Company Information Table 69. Dinuo Pharmaceutical Business Overview Table 70. Dinuo Pharmaceutical HMG-CoA Reductase Inhibitors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Dinuo Pharmaceutical HMG-CoA Reductase Inhibitors Product Portfolio Table 72. Dinuo Pharmaceutical Recent Developments Table 73. Hanhui Pharmaceuticals Company Information Table 74. Hanhui Pharmaceuticals Business Overview Table 75. Hanhui Pharmaceuticals HMG-CoA Reductase Inhibitors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Hanhui Pharmaceuticals HMG-CoA Reductase Inhibitors Product Portfolio Table 77. Hanhui Pharmaceuticals Recent Developments Table 78. Daiichi Sankyo Company Information Table 79. Daiichi Sankyo Business Overview Table 80. Daiichi Sankyo HMG-CoA Reductase Inhibitors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Daiichi Sankyo HMG-CoA Reductase Inhibitors Product Portfolio Table 82. Daiichi Sankyo Recent Developments Table 83. Sanofi-Aventis Company Information Table 84. Sanofi-Aventis Business Overview Table 85. Sanofi-Aventis HMG-CoA Reductase Inhibitors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Sanofi-Aventis HMG-CoA Reductase Inhibitors Product Portfolio Table 87. Sanofi-Aventis Recent Developments Table 88. Pfizer Company Information Table 89. Pfizer Business Overview Table 90. Pfizer HMG-CoA Reductase Inhibitors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Pfizer HMG-CoA Reductase Inhibitors Product Portfolio Table 92. Pfizer Recent Developments Table 93. AstraZeneca Company Information Table 94. AstraZeneca Business Overview Table 95. AstraZeneca HMG-CoA Reductase Inhibitors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. AstraZeneca HMG-CoA Reductase Inhibitors Product Portfolio Table 97. AstraZeneca Recent Developments Table 98. Global HMG-CoA Reductase Inhibitors Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 99. Global HMG-CoA Reductase Inhibitors Sales by Region (2021-2026) & (Units) Table 100. Global HMG-CoA Reductase Inhibitors Sales Market Share by Region (2021-2026) Table 101. Global HMG-CoA Reductase Inhibitors Sales by Region (2027-2032) & (Units) Table 102. Global HMG-CoA Reductase Inhibitors Sales Market Share by Region (2027-2032) Table 103. Global HMG-CoA Reductase Inhibitors Revenue by Region (2021-2026) & (US$ Million) Table 104. Global HMG-CoA Reductase Inhibitors Revenue Market Share by Region (2021-2026) Table 105. Global HMG-CoA Reductase Inhibitors Revenue by Region (2027-2032) & (US$ Million) Table 106. Global HMG-CoA Reductase Inhibitors Revenue Market Share by Region (2027-2032) Table 107. North America HMG-CoA Reductase Inhibitors Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. North America HMG-CoA Reductase Inhibitors Sales by Country (2021-2026) & (Units) Table 109. North America HMG-CoA Reductase Inhibitors Sales by Country (2027-2032) & (Units) Table 110. North America HMG-CoA Reductase Inhibitors Revenue by Country (2021-2026) & (US$ Million) Table 111. North America HMG-CoA Reductase Inhibitors Revenue by Country (2027-2032) & (US$ Million) Table 112. Europe HMG-CoA Reductase Inhibitors Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Europe HMG-CoA Reductase Inhibitors Sales by Country (2021-2026) & (Units) Table 114. Europe HMG-CoA Reductase Inhibitors Sales by Country (2027-2032) & (Units) Table 115. Europe HMG-CoA Reductase Inhibitors Revenue by Country (2021-2026) & (US$ Million) Table 116. Europe HMG-CoA Reductase Inhibitors Revenue by Country (2027-2032) & (US$ Million) Table 117. Asia Pacific HMG-CoA Reductase Inhibitors Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Asia Pacific HMG-CoA Reductase Inhibitors Sales by Country (2021-2026) & (Units) Table 119. Asia Pacific HMG-CoA Reductase Inhibitors Sales by Country (2027-2032) & (Units) Table 120. Asia Pacific HMG-CoA Reductase Inhibitors Revenue by Country (2021-2026) & (US$ Million) Table 121. Asia Pacific HMG-CoA Reductase Inhibitors Revenue by Country (2027-2032) & (US$ Million) Table 122. South America HMG-CoA Reductase Inhibitors Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. South America HMG-CoA Reductase Inhibitors Sales by Country (2021-2026) & (Units) Table 124. South America HMG-CoA Reductase Inhibitors Sales by Country (2027-2032) & (Units) Table 125. South America HMG-CoA Reductase Inhibitors Revenue by Country (2021-2026) & (US$ Million) Table 126. South America HMG-CoA Reductase Inhibitors Revenue by Country (2027-2032) & (US$ Million) Table 127. Middle East and Africa HMG-CoA Reductase Inhibitors Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Middle East and Africa HMG-CoA Reductase Inhibitors Sales by Country (2021-2026) & (Units) Table 129. Middle East and Africa HMG-CoA Reductase Inhibitors Sales by Country (2027-2032) & (Units) Table 130. Middle East and Africa HMG-CoA Reductase Inhibitors Revenue by Country (2021-2026) & (US$ Million) Table 131. Middle East and Africa HMG-CoA Reductase Inhibitors Revenue by Country (2027-2032) & (US$ Million) Table 132. Global HMG-CoA Reductase Inhibitors Sales by Type (2021-2026) & (Units) Table 133. Global HMG-CoA Reductase Inhibitors Sales by Type (2027-2032) & (Units) Table 134. Global HMG-CoA Reductase Inhibitors Sales Market Share by Type (2021-2026) Table 135. Global HMG-CoA Reductase Inhibitors Sales Market Share by Type (2027-2032) Table 136. Global HMG-CoA Reductase Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 137. Global HMG-CoA Reductase Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 138. Global HMG-CoA Reductase Inhibitors Revenue Market Share by Type (2021-2026) Table 139. Global HMG-CoA Reductase Inhibitors Revenue Market Share by Type (2027-2032) Table 140. Global HMG-CoA Reductase Inhibitors Price by Type (2021-2026) & (US$/Unit) Table 141. Global HMG-CoA Reductase Inhibitors Price by Type (2027-2032) & (US$/Unit) Table 142. Global HMG-CoA Reductase Inhibitors Sales by Application (2021-2026) & (Units) Table 143. Global HMG-CoA Reductase Inhibitors Sales by Application (2027-2032) & (Units) Table 144. Global HMG-CoA Reductase Inhibitors Sales Market Share by Application (2021-2026) Table 145. Global HMG-CoA Reductase Inhibitors Sales Market Share by Application (2027-2032) Table 146. Global HMG-CoA Reductase Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 147. Global HMG-CoA Reductase Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 148. Global HMG-CoA Reductase Inhibitors Revenue Market Share by Application (2021-2026) Table 149. Global HMG-CoA Reductase Inhibitors Revenue Market Share by Application (2027-2032) Table 150. Global HMG-CoA Reductase Inhibitors Price by Application (2021-2026) & (US$/Unit) Table 151. Global HMG-CoA Reductase Inhibitors Price by Application (2027-2032) & (US$/Unit) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. HMG-CoA Reductase Inhibitors Distributors List Table 155. HMG-CoA Reductase Inhibitors Customers List Table 156. HMG-CoA Reductase Inhibitors Industry Trends Table 157. HMG-CoA Reductase Inhibitors Industry Drivers Table 158. HMG-CoA Reductase Inhibitors Industry Restraints Table 159. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. HMG-CoA Reductase Inhibitors Product Image Figure 5. Global HMG-CoA Reductase Inhibitors Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global HMG-CoA Reductase Inhibitors Market Size (2021-2032) & (US$ Million) Figure 7. Global HMG-CoA Reductase Inhibitors Sales (2021-2032) & (Units) Figure 8. Global HMG-CoA Reductase Inhibitors Average Price (US$/Unit) & (2021-2032) Figure 9. Simvastatin Product Image Figure 10. Rosuvastatin Product Image Figure 11. Atorvastatin Product Image Figure 12. Others Product Image Figure 13. Hospital Product Image Figure 14. Clinic Product Image Figure 15. Others Product Image Figure 16. Global HMG-CoA Reductase Inhibitors Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of HMG-CoA Reductase Inhibitors, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 HMG-CoA Reductase Inhibitors Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global HMG-CoA Reductase Inhibitors Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global HMG-CoA Reductase Inhibitors Sales by Region in 2025 Figure 22. Global HMG-CoA Reductase Inhibitors Revenue by Region in 2025 Figure 23. North America HMG-CoA Reductase Inhibitors Market Size by Country in 2025 Figure 24. North America HMG-CoA Reductase Inhibitors Sales Market Share by Country (2021-2032) Figure 25. North America HMG-CoA Reductase Inhibitors Revenue Market Share by Country (2021-2032) Figure 26. United States HMG-CoA Reductase Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada HMG-CoA Reductase Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico HMG-CoA Reductase Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe HMG-CoA Reductase Inhibitors Market Size by Country in 2025 Figure 30. Europe HMG-CoA Reductase Inhibitors Sales Market Share by Country (2021-2032) Figure 31. Europe HMG-CoA Reductase Inhibitors Revenue Market Share by Country (2021-2032) Figure 32. Germany HMG-CoA Reductase Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France HMG-CoA Reductase Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. HMG-CoA Reductase Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy HMG-CoA Reductase Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia HMG-CoA Reductase Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain HMG-CoA Reductase Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands HMG-CoA Reductase Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland HMG-CoA Reductase Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden HMG-CoA Reductase Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland HMG-CoA Reductase Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific HMG-CoA Reductase Inhibitors Market Size by Country in 2025 Figure 43. Asia Pacific HMG-CoA Reductase Inhibitors Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific HMG-CoA Reductase Inhibitors Revenue Market Share by Country (2021-2032) Figure 45. China HMG-CoA Reductase Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan HMG-CoA Reductase Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea HMG-CoA Reductase Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India HMG-CoA Reductase Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia HMG-CoA Reductase Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan HMG-CoA Reductase Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia HMG-CoA Reductase Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia HMG-CoA Reductase Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America HMG-CoA Reductase Inhibitors Market Size by Country in 2025 Figure 54. South America HMG-CoA Reductase Inhibitors Sales Market Share by Country (2021-2032) Figure 55. South America HMG-CoA Reductase Inhibitors Revenue Market Share by Country (2021-2032) Figure 56. Brazil HMG-CoA Reductase Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina HMG-CoA Reductase Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile HMG-CoA Reductase Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa HMG-CoA Reductase Inhibitors Market Size by Country in 2025 Figure 60. Middle East and Africa HMG-CoA Reductase Inhibitors Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa HMG-CoA Reductase Inhibitors Revenue Market Share by Country (2021-2032) Figure 62. Egypt HMG-CoA Reductase Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa HMG-CoA Reductase Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel HMG-CoA Reductase Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye HMG-CoA Reductase Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries HMG-CoA Reductase Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global HMG-CoA Reductase Inhibitors Sales Market Share by Type (2021-2032) Figure 68. Global HMG-CoA Reductase Inhibitors Revenue Market Share by Type (2021-2032) Figure 69. Global HMG-CoA Reductase Inhibitors Price (US$/Unit) by Type (2021-2032) Figure 70. Global HMG-CoA Reductase Inhibitors Sales Market Share by Application (2021-2032) Figure 71. Global HMG-CoA Reductase Inhibitors Revenue Market Share by Application (2021-2032) Figure 72. Global HMG-CoA Reductase Inhibitors Price (US$/Unit) by Application (2021-2032) Figure 73. HMG-CoA Reductase Inhibitors Value Chain Figure 74. HMG-CoA Reductase Inhibitors Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. HMG-CoA Reductase Inhibitors Industry Opportunities and Challenges

Scope & coverage.

Types
  • Simvastatin
  • Rosuvastatin
  • Atorvastatin
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • CTTQ
  • Simcere
  • Wanbang Biopharmaceuticals
  • Lek Pharmaceuticals
  • Qilu Pharmaceutical
  • Novartis
  • Merck Sharp & Dohme
  • Lepu Pharmaceuticals
  • Jiurui Health
  • Jialin Pharmaceutical
  • Dinuo Pharmaceutical
  • Hanhui Pharmaceuticals
  • Daiichi Sankyo
  • Sanofi-Aventis
  • Pfizer
  • AstraZeneca

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global HMG-CoA Reductase Inhibitors Market Size (2021-2032)
  4. 2.2.2 Global HMG-CoA Reductase Inhibitors Sales (2021-2032)
  5. 2.2.3 Global HMG-CoA Reductase Inhibitors Market Average Price (2021-2032)
  6. 2.3 HMG-CoA Reductase Inhibitors by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Simvastatin
  9. 2.3.3 Rosuvastatin
  10. 2.3.4 Atorvastatin
  11. 2.3.5 Others
  12. 2.4 HMG-CoA Reductase Inhibitors by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Hospital
  15. 2.4.3 Clinic
  16. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global HMG-CoA Reductase Inhibitors Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global HMG-CoA Reductase Inhibitors Sales (Units) of Manufacturers (2021-2026)
  3. 3.3 Global HMG-CoA Reductase Inhibitors Revenue of Manufacturers (2021-2026)
  4. 3.4 Global HMG-CoA Reductase Inhibitors Average Price by Manufacturers (2021-2026)
  5. 3.5 Global HMG-CoA Reductase Inhibitors Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of HMG-CoA Reductase Inhibitors, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of HMG-CoA Reductase Inhibitors, Product Type & Application
  8. 3.8 Global Manufacturers of HMG-CoA Reductase Inhibitors, Established Date
  9. 3.9 Global HMG-CoA Reductase Inhibitors Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 CTTQ
  2. 4.1.1 CTTQ Company Information
  3. 4.1.2 CTTQ Business Overview
  4. 4.1.3 CTTQ HMG-CoA Reductase Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 CTTQ HMG-CoA Reductase Inhibitors Product Portfolio
  6. 4.1.5 CTTQ Recent Developments
  7. 4.2 Simcere
  8. 4.2.1 Simcere Company Information
  9. 4.2.2 Simcere Business Overview
  10. 4.2.3 Simcere HMG-CoA Reductase Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Simcere HMG-CoA Reductase Inhibitors Product Portfolio
  12. 4.2.5 Simcere Recent Developments
  13. 4.3 Wanbang Biopharmaceuticals
  14. 4.3.1 Wanbang Biopharmaceuticals Company Information
  15. 4.3.2 Wanbang Biopharmaceuticals Business Overview
  16. 4.3.3 Wanbang Biopharmaceuticals HMG-CoA Reductase Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Wanbang Biopharmaceuticals HMG-CoA Reductase Inhibitors Product Portfolio
  18. 4.3.5 Wanbang Biopharmaceuticals Recent Developments
  19. 4.4 Lek Pharmaceuticals
  20. 4.4.1 Lek Pharmaceuticals Company Information
  21. 4.4.2 Lek Pharmaceuticals Business Overview
  22. 4.4.3 Lek Pharmaceuticals HMG-CoA Reductase Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Lek Pharmaceuticals HMG-CoA Reductase Inhibitors Product Portfolio
  24. 4.4.5 Lek Pharmaceuticals Recent Developments
  25. 4.5 Qilu Pharmaceutical
  26. 4.5.1 Qilu Pharmaceutical Company Information
  27. 4.5.2 Qilu Pharmaceutical Business Overview
  28. 4.5.3 Qilu Pharmaceutical HMG-CoA Reductase Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Qilu Pharmaceutical HMG-CoA Reductase Inhibitors Product Portfolio
  30. 4.5.5 Qilu Pharmaceutical Recent Developments
  31. 4.6 Novartis
  32. 4.6.1 Novartis Company Information
  33. 4.6.2 Novartis Business Overview
  34. 4.6.3 Novartis HMG-CoA Reductase Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Novartis HMG-CoA Reductase Inhibitors Product Portfolio
  36. 4.6.5 Novartis Recent Developments
  37. 4.7 Merck Sharp & Dohme
  38. 4.7.1 Merck Sharp & Dohme Company Information
  39. 4.7.2 Merck Sharp & Dohme Business Overview
  40. 4.7.3 Merck Sharp & Dohme HMG-CoA Reductase Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Merck Sharp & Dohme HMG-CoA Reductase Inhibitors Product Portfolio
  42. 4.7.5 Merck Sharp & Dohme Recent Developments
  43. 4.8 Lepu Pharmaceuticals
  44. 4.8.1 Lepu Pharmaceuticals Company Information
  45. 4.8.2 Lepu Pharmaceuticals Business Overview
  46. 4.8.3 Lepu Pharmaceuticals HMG-CoA Reductase Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Lepu Pharmaceuticals HMG-CoA Reductase Inhibitors Product Portfolio
  48. 4.8.5 Lepu Pharmaceuticals Recent Developments
  49. 4.9 Jiurui Health
  50. 4.9.1 Jiurui Health Company Information
  51. 4.9.2 Jiurui Health Business Overview
  52. 4.9.3 Jiurui Health HMG-CoA Reductase Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Jiurui Health HMG-CoA Reductase Inhibitors Product Portfolio
  54. 4.9.5 Jiurui Health Recent Developments
  55. 4.10 Jialin Pharmaceutical
  56. 4.10.1 Jialin Pharmaceutical Company Information
  57. 4.10.2 Jialin Pharmaceutical Business Overview
  58. 4.10.3 Jialin Pharmaceutical HMG-CoA Reductase Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Jialin Pharmaceutical HMG-CoA Reductase Inhibitors Product Portfolio
  60. 4.10.5 Jialin Pharmaceutical Recent Developments
  61. 4.11 Dinuo Pharmaceutical
  62. 4.11.1 Dinuo Pharmaceutical Company Information
  63. 4.11.2 Dinuo Pharmaceutical Business Overview
  64. 4.11.3 Dinuo Pharmaceutical HMG-CoA Reductase Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Dinuo Pharmaceutical HMG-CoA Reductase Inhibitors Product Portfolio
  66. 4.11.5 Dinuo Pharmaceutical Recent Developments
  67. 4.12 Hanhui Pharmaceuticals
  68. 4.12.1 Hanhui Pharmaceuticals Company Information
  69. 4.12.2 Hanhui Pharmaceuticals Business Overview
  70. 4.12.3 Hanhui Pharmaceuticals HMG-CoA Reductase Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Hanhui Pharmaceuticals HMG-CoA Reductase Inhibitors Product Portfolio
  72. 4.12.5 Hanhui Pharmaceuticals Recent Developments
  73. 4.13 Daiichi Sankyo
  74. 4.13.1 Daiichi Sankyo Company Information
  75. 4.13.2 Daiichi Sankyo Business Overview
  76. 4.13.3 Daiichi Sankyo HMG-CoA Reductase Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Daiichi Sankyo HMG-CoA Reductase Inhibitors Product Portfolio
  78. 4.13.5 Daiichi Sankyo Recent Developments
  79. 4.14 Sanofi-Aventis
  80. 4.14.1 Sanofi-Aventis Company Information
  81. 4.14.2 Sanofi-Aventis Business Overview
  82. 4.14.3 Sanofi-Aventis HMG-CoA Reductase Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Sanofi-Aventis HMG-CoA Reductase Inhibitors Product Portfolio
  84. 4.14.5 Sanofi-Aventis Recent Developments
  85. 4.15 Pfizer
  86. 4.15.1 Pfizer Company Information
  87. 4.15.2 Pfizer Business Overview
  88. 4.15.3 Pfizer HMG-CoA Reductase Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Pfizer HMG-CoA Reductase Inhibitors Product Portfolio
  90. 4.15.5 Pfizer Recent Developments
  91. 4.16 AstraZeneca
  92. 4.16.1 AstraZeneca Company Information
  93. 4.16.2 AstraZeneca Business Overview
  94. 4.16.3 AstraZeneca HMG-CoA Reductase Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 AstraZeneca HMG-CoA Reductase Inhibitors Product Portfolio
  96. 4.16.5 AstraZeneca Recent Developments
5 Global HMG-CoA Reductase Inhibitors Market Scenario by Region
  1. 5.1 Global HMG-CoA Reductase Inhibitors Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global HMG-CoA Reductase Inhibitors Sales by Region: 2021-2032
  3. 5.2.1 Global HMG-CoA Reductase Inhibitors Sales by Region: 2021-2026
  4. 5.2.2 Global HMG-CoA Reductase Inhibitors Sales by Region: 2027-2032
  5. 5.3 Global HMG-CoA Reductase Inhibitors Revenue by Region: 2021-2032
  6. 5.3.1 Global HMG-CoA Reductase Inhibitors Revenue by Region: 2021-2026
  7. 5.3.2 Global HMG-CoA Reductase Inhibitors Revenue by Region: 2027-2032
  8. 5.4 North America HMG-CoA Reductase Inhibitors Market Facts & Figures by Country
  9. 5.4.1 North America HMG-CoA Reductase Inhibitors Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America HMG-CoA Reductase Inhibitors Sales by Country (2021-2032)
  11. 5.4.3 North America HMG-CoA Reductase Inhibitors Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe HMG-CoA Reductase Inhibitors Market Facts & Figures by Country
  16. 5.5.1 Europe HMG-CoA Reductase Inhibitors Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe HMG-CoA Reductase Inhibitors Sales by Country (2021-2032)
  18. 5.5.3 Europe HMG-CoA Reductase Inhibitors Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific HMG-CoA Reductase Inhibitors Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific HMG-CoA Reductase Inhibitors Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific HMG-CoA Reductase Inhibitors Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific HMG-CoA Reductase Inhibitors Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America HMG-CoA Reductase Inhibitors Market Facts & Figures by Country
  41. 5.7.1 South America HMG-CoA Reductase Inhibitors Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America HMG-CoA Reductase Inhibitors Sales by Country (2021-2032)
  43. 5.7.3 South America HMG-CoA Reductase Inhibitors Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa HMG-CoA Reductase Inhibitors Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa HMG-CoA Reductase Inhibitors Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa HMG-CoA Reductase Inhibitors Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa HMG-CoA Reductase Inhibitors Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global HMG-CoA Reductase Inhibitors Sales by Type (2021-2032)
  2. 6.1.1 Global HMG-CoA Reductase Inhibitors Sales by Type (2021-2032) & (Units)
  3. 6.1.2 Global HMG-CoA Reductase Inhibitors Sales Market Share by Type (2021-2032)
  4. 6.2 Global HMG-CoA Reductase Inhibitors Revenue by Type (2021-2032)
  5. 6.2.1 Global HMG-CoA Reductase Inhibitors Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global HMG-CoA Reductase Inhibitors Revenue Market Share by Type (2021-2032)
  7. 6.3 Global HMG-CoA Reductase Inhibitors Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global HMG-CoA Reductase Inhibitors Sales by Application (2021-2032)
  2. 7.1.1 Global HMG-CoA Reductase Inhibitors Sales by Application (2021-2032) & (Units)
  3. 7.1.2 Global HMG-CoA Reductase Inhibitors Sales Market Share by Application (2021-2032)
  4. 7.2 Global HMG-CoA Reductase Inhibitors Revenue by Application (2021-2032)
  5. 7.2.1 Global HMG-CoA Reductase Inhibitors Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global HMG-CoA Reductase Inhibitors Revenue Market Share by Application (2021-2032)
  7. 7.3 Global HMG-CoA Reductase Inhibitors Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 HMG-CoA Reductase Inhibitors Value Chain Analysis
  2. 8.1.1 HMG-CoA Reductase Inhibitors Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 HMG-CoA Reductase Inhibitors Production Mode & Process
  5. 8.2 HMG-CoA Reductase Inhibitors Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 HMG-CoA Reductase Inhibitors Distributors
  8. 8.2.3 HMG-CoA Reductase Inhibitors Customers
9 Global HMG-CoA Reductase Inhibitors Analyzing Market Dynamics
  1. 9.1 HMG-CoA Reductase Inhibitors Industry Trends
  2. 9.2 HMG-CoA Reductase Inhibitors Industry Drivers
  3. 9.3 HMG-CoA Reductase Inhibitors Industry Opportunities and Challenges
  4. 9.4 HMG-CoA Reductase Inhibitors Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst